Luu, S.; Province, H.; Berry-Kravis, E.; Hagerman, R.; Hessl, D.; Vaidya, D.; Lozano, R.; Rosselot, H.; Erickson, C.; Kaufmann, W.E.;
et al. Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis. Brain Sci. 2020, 10, 629.
https://doi.org/10.3390/brainsci10090629
AMA Style
Luu S, Province H, Berry-Kravis E, Hagerman R, Hessl D, Vaidya D, Lozano R, Rosselot H, Erickson C, Kaufmann WE,
et al. Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis. Brain Sciences. 2020; 10(9):629.
https://doi.org/10.3390/brainsci10090629
Chicago/Turabian Style
Luu, Skylar, Haley Province, Elizabeth Berry-Kravis, Randi Hagerman, David Hessl, Dhananjay Vaidya, Reymundo Lozano, Hilary Rosselot, Craig Erickson, Walter E. Kaufmann,
and et al. 2020. "Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis" Brain Sciences 10, no. 9: 629.
https://doi.org/10.3390/brainsci10090629
APA Style
Luu, S., Province, H., Berry-Kravis, E., Hagerman, R., Hessl, D., Vaidya, D., Lozano, R., Rosselot, H., Erickson, C., Kaufmann, W. E., & Budimirovic, D. B.
(2020). Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis. Brain Sciences, 10(9), 629.
https://doi.org/10.3390/brainsci10090629